Enduring Material

Something for the Pain – Season 2
Show Notes: Episode 20: Nicole Fox – Marijuana Use in the Perinatal Period
Featuring: Nicole Fox, M.D., M.P.A., Psychiatry, St. Luke’s Health System
Didactic Presentation Details
- Didactic Presenter: Nicole Fox, M.D., M.P.A., Psychiatry, St. Luke’s Health System
- Didactic Presentation Title: “Marijuana Use in the Perinatal Period”
- Didactic Presentation Date:
- ECHO Idaho Series: Perinatal Substance Use Disorder series
- Didactic Presentation Video: https://youtu.be/wdNTA1jl5OM
- Didactic Presentation Slides: https://iecho.unm.edu/sites/uidaho/download.hns?is=5989a8065878e1721e28f0d8c02084d9

Resources and Publications Mentioned
- Fox, Hayey. “Weed and Pregnancy: How Cannabis Laws Are Hurting Mothers.” Rolling Stone Magazine. Nov. 17, 2018: https://www.rollingstone.com/culture/culture-features/weed-pregnancy-mother-family-marijuana-cannabis-755697/
- Oster, Emily. “New Evidence on Pot During Pregnancy.” The Atlantic. July 8, 2019: https://www.theatlantic.com/ideas/archive/2019/07/smoke-pot-during-pregnancy/593101/
- CDC: “Marijuana Use and Pregnancy”: https://www.cdc.gov/marijuana/health-effects/pregnancy.html
- “Surgeon General’s Advisory: Marijuana Use and the Developing Brain”: https://www.hhs.gov/surgeongeneral/reports-and-publications/addiction-and-substance-misuse/advisory-on-marijuana-use-and-developing-brain/index.html
- “Marijuana”: https://mothertobaby.org/fact-sheets/marijuana-pregnancy/
- “The Effects of Marijuana on Fetal Development”: https://womensmentalhealth.org/posts/effects-marijuana-embryo-development/
- Prozac: https://medlineplus.gov/druginfo/meds/a689006.html
- Zoloft: https://medlineplus.gov/druginfo/meds/a697048.html
- Sertraline: https://medlineplus.gov/druginfo/meds/a697048.html
- Fluoxetine: https://medlineplus.gov/druginfo/meds/a689006.html
- Friedrich, J., Khatib, D., Pars, K. et al. “The Grass Isn’t Always Greener: the Effects of Cannabis on Embryological Development.” BMC Pharmacoll Toxicol 17, 45 (2016): https://bmcpharmacoltoxicol.biomedcentral.com/articles/10.1186/s40360-016-0085-6

• Apply trauma-informed and harm-reduction strategies to improve patient outcomes and quality of care.
• Determine best practices in care for patients with perinatal substance use disorders in order to reduce medical errors.
• Discuss the medication and treatment options available to patients for treating substance and opioid use disorder during pregnancy and postpartum.
• Identify Idaho-specific resources available to patients and caregivers in order to reduce harms associated with substance use disorders.

Episode 20: Nicole Fox - Marijuana Use in the Perinatal Period

• Nicole Fox, MD
• Stacy Seyb, MD
• Jerri Woodworth, RN
• Laresa Janousek, APRN
• Lachelle Smith, MPP

• The University of Idaho, WWAMI Medical Education Program designates this enduring material for a maximum of 0.5 AMA PRA Category 1 Credits™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.
• The University of Idaho, WWAMI Medical Education Program designates this enduring material for a maximum of 0.5 Attendance w/ No Credit. This is an approved continuing education activity, and participants can submit a certificate to the Idaho Division of Occupational and Professional Licensing (e.g., counselors, marriage and family therapists, social workers, alcohol and drug counselors [CADC/ACADC/CPS]) for credit. Participants should claim only the credit commensurate with the extent of their participation in the activity.
• The University of Idaho, WWAMI Medical Education Program designates this enduring material for a maximum of 0.5 Hour(s) APA. Participants should claim only the credit commensurate with the extent of their participation in the activity.
• 

  The University of Idaho, WWAMI Medical Education Program has been authorized by the American Academy of PAs (AAPA) to award AAPA Category 1 CME credit for activities planned in accordance with AAPA CME Criteria. This activity is designated for 0.5 AAPA Category 1 CME credits. PAs should only claim credit commensurate with the extent of their participation.
• This activity was planned by and for the healthcare team, and learners will receive 0.5 Interprofessional Continuing Education (IPCE) credit for learning and change.
• The University of Idaho, WWAMI Medical Education Program designates this enduring material for a maximum of 0.5 Hour(s) NCPD (ANCC Contact Hours). Participants should claim only the credit commensurate with the extent of their participation in the activity.

None of the planners or presenters for this educational activity have relevant financial relationship(s) to disclose with ineligible companies whose primary business is producing, marketing, selling, re-selling, or distributing healthcare products used by or on patients.

80 %

0 %

6/28/2022